Raghavan Sudhir, Baskin David S, Sharpe Martyn A
Department of Neurosurgery, Kenneth R. Peak Brain and Pituitary Tumor Center, Houston Methodist Hospital, 6670 Bertner Ave, Houston, TX 77030, USA.
Cancers (Basel). 2020 Feb 14;12(2):453. doi: 10.3390/cancers12020453.
Various pathways can repair DNA alkylation by chemotherapeutic agents such as temozolomide (TMZ). The enzyme O-methylguanine methyltransferase (MGMT) removes O-methylated DNA adducts, leading to the failure of chemotherapy in resistant glioblastomas. Because of the anti-chemotherapeutic activities of MGMT previously described, estimating the levels of active MGMT in cancer cells can be a significant predictor of response to alkylating agents. Current methods to detect MGMT in cells are indirect, complicated, time-intensive, or utilize molecules that require complex and multistep chemistry synthesis. Our design simulates DNA repair by the transfer of a clickable propargyl group from O-propargyl guanine to active MGMT and subsequent attachment of fluorescein-linked PEG linker via "click chemistry." Visualization of active MGMT levels reveals discrete active and inactive MGMT populations with biphasic kinetics for MGMT inactivation in response to TMZ-induced DNA damage.
多种途径可修复由替莫唑胺(TMZ)等化疗药物引起的DNA烷基化。O-甲基鸟嘌呤甲基转移酶(MGMT)可去除O-甲基化的DNA加合物,导致耐药性胶质母细胞瘤化疗失败。鉴于之前所述的MGMT的抗化疗活性,估计癌细胞中活性MGMT的水平可能是对烷化剂反应的重要预测指标。目前检测细胞中MGMT的方法是间接的、复杂的、耗时的,或者使用需要复杂多步化学合成的分子。我们的设计通过将可点击的炔丙基从O-炔丙基鸟嘌呤转移到活性MGMT,并随后通过“点击化学”连接荧光素连接的聚乙二醇接头来模拟DNA修复。活性MGMT水平的可视化揭示了离散的活性和非活性MGMT群体,其对TMZ诱导的DNA损伤的MGMT失活具有双相动力学。